Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Jolly

Showing results (191-200 of 233) with videos related to

Pageof 24
Sort By:
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 1, 2021
Histopathologic analysis of extracted thrombi from deep venous thrombosis and pulmonary embolism: Mechanisms and timingMitchell J Silver, Rika Kawakami, Michael A Jolly, et al.
Breast Cancer Research and Treatment|November 11, 2017
Measuring and understanding adherence in a home-based exercise intervention during chemotherapy for early breast cancerK A Nyrop, A M Deal, S K Choi, et al.
Breast Cancer Research and Treatment|October 12, 2018
Correction to: Measuring and understanding adherence in a home-based exercise intervention during chemotherapy for early breast cancerK A Nyrop, A M Deal, S K Choi, et al.
Environmental Health Perspectives|March 23, 2004
Clofibrate-induced gene expression changes in rat liver: a cross-laboratory analysis using membrane cDNA arraysValerie A Baker, Helen M Harries, Jeff F Waring, et al.
Regulatory Toxicology and Pharmacology : RTP|August 14, 2022
Setting impurity limits for endogenous substances: Recommendations for a harmonized procedure and an example using fatty acidsRobert A Jolly, Suren Bandara, Joel Bercu, et al.
The Oncologist|March 14, 2015
Geriatric assessment-identified deficits in older cancer patients with normal performance statusTrevor A Jolly, Allison M Deal, Kirsten A Nyrop, et al.
Regulatory Toxicology and Pharmacology : RTP|June 9, 2016
A harmonization effort for acceptable daily exposure application to pharmaceutical manufacturing - Operational considerationsEileen P Hayes, Robert A Jolly, Ellen C Faria, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|January 27, 2007
Underlying mechanisms of pharmacology and toxicity of a novel PPAR agonist revealed using rodent and canine hepatocytesYin Guo, Robert A Jolly, Bartley W Halstead, et al.
NPJ Breast Cancer|September 8, 2022
A biomarker of aging, p16, predicts peripheral neuropathy in women receiving adjuvant taxanes for breast cancerNatalia Mitin, Kirsten A Nyrop, Susan L Strum, et al.
Scientific Reports|July 2, 2017
Viperin is an important host restriction factor in control of Zika virus infectionKylie H Van der Hoek, Nicholas S Eyre, Byron Shue, et al.
Pageof 24

Showing results (191-200 of 233) with videos related to

Sort By:
Pageof 24
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 1, 2021
Histopathologic analysis of extracted thrombi from deep venous thrombosis and pulmonary embolism: Mechanisms and timingMitchell J Silver, Rika Kawakami, Michael A Jolly, et al.
Breast Cancer Research and Treatment|November 11, 2017
Measuring and understanding adherence in a home-based exercise intervention during chemotherapy for early breast cancerK A Nyrop, A M Deal, S K Choi, et al.
Breast Cancer Research and Treatment|October 12, 2018
Correction to: Measuring and understanding adherence in a home-based exercise intervention during chemotherapy for early breast cancerK A Nyrop, A M Deal, S K Choi, et al.
Environmental Health Perspectives|March 23, 2004
Clofibrate-induced gene expression changes in rat liver: a cross-laboratory analysis using membrane cDNA arraysValerie A Baker, Helen M Harries, Jeff F Waring, et al.
Regulatory Toxicology and Pharmacology : RTP|August 14, 2022
Setting impurity limits for endogenous substances: Recommendations for a harmonized procedure and an example using fatty acidsRobert A Jolly, Suren Bandara, Joel Bercu, et al.
The Oncologist|March 14, 2015
Geriatric assessment-identified deficits in older cancer patients with normal performance statusTrevor A Jolly, Allison M Deal, Kirsten A Nyrop, et al.
Regulatory Toxicology and Pharmacology : RTP|June 9, 2016
A harmonization effort for acceptable daily exposure application to pharmaceutical manufacturing - Operational considerationsEileen P Hayes, Robert A Jolly, Ellen C Faria, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|January 27, 2007
Underlying mechanisms of pharmacology and toxicity of a novel PPAR agonist revealed using rodent and canine hepatocytesYin Guo, Robert A Jolly, Bartley W Halstead, et al.
NPJ Breast Cancer|September 8, 2022
A biomarker of aging, p16, predicts peripheral neuropathy in women receiving adjuvant taxanes for breast cancerNatalia Mitin, Kirsten A Nyrop, Susan L Strum, et al.
Scientific Reports|July 2, 2017
Viperin is an important host restriction factor in control of Zika virus infectionKylie H Van der Hoek, Nicholas S Eyre, Byron Shue, et al.
Pageof 24